268 related articles for article (PubMed ID: 26749528)
1. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
Lee RH; Bergmeier W
J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
[TBL] [Abstract][Full Text] [Related]
2. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
[TBL] [Abstract][Full Text] [Related]
3. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
[TBL] [Abstract][Full Text] [Related]
4. Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.
Boulaftali Y; Hess PR; Kahn ML; Bergmeier W
Circ Res; 2014 Mar; 114(7):1174-84. PubMed ID: 24677237
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets.
Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP
J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354
[TBL] [Abstract][Full Text] [Related]
6. GPVI and CLEC-2 in hemostasis and vascular integrity.
Watson SP; Herbert JM; Pollitt AY
J Thromb Haemost; 2010 Jul; 8(7):1456-67. PubMed ID: 20345705
[TBL] [Abstract][Full Text] [Related]
7. CLEC-2 expression is maintained on activated platelets and on platelet microparticles.
Gitz E; Pollitt AY; Gitz-Francois JJ; Alshehri O; Mori J; Montague S; Nash GB; Douglas MR; Gardiner EE; Andrews RK; Buckley CD; Harrison P; Watson SP
Blood; 2014 Oct; 124(14):2262-70. PubMed ID: 25150298
[TBL] [Abstract][Full Text] [Related]
8. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
[TBL] [Abstract][Full Text] [Related]
9. Platelet ITAM signaling.
Bergmeier W; Stefanini L
Curr Opin Hematol; 2013 Sep; 20(5):445-50. PubMed ID: 23921514
[TBL] [Abstract][Full Text] [Related]
10. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F
Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
[TBL] [Abstract][Full Text] [Related]
11. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
[TBL] [Abstract][Full Text] [Related]
12. Platelet ITAM signaling is critical for vascular integrity in inflammation.
Boulaftali Y; Hess PR; Getz TM; Cholka A; Stolla M; Mackman N; Owens AP; Ware J; Kahn ML; Bergmeier W
J Clin Invest; 2013 Feb; 123(2):908-16. PubMed ID: 23348738
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2.
Zhi Z; Jooss NJ; Sun Y; Colicchia M; Slater A; Moran LA; Cheung HYF; Di Y; Rayes J; Poulter NS; Watson SP; Iqbal AJ
J Thromb Haemost; 2022 Apr; 20(4):936-950. PubMed ID: 34936188
[TBL] [Abstract][Full Text] [Related]
14. Impact of the PI3-kinase/Akt pathway on ITAM and hemITAM receptors: haemostasis, platelet activation and antithrombotic therapy.
Moroi AJ; Watson SP
Biochem Pharmacol; 2015 Apr; 94(3):186-94. PubMed ID: 25698506
[TBL] [Abstract][Full Text] [Related]
15. Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI.
Ozaki Y; Suzuki-Inoue K; Inoue O
J Thromb Haemost; 2009 Jul; 7 Suppl 1():191-4. PubMed ID: 19630798
[TBL] [Abstract][Full Text] [Related]
16. Novel platelet activation receptor CLEC-2: from discovery to prospects.
Suzuki-Inoue K; Inoue O; Ozaki Y
J Thromb Haemost; 2011 Jul; 9 Suppl 1():44-55. PubMed ID: 21781241
[TBL] [Abstract][Full Text] [Related]
17. Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2).
Hughes CE; Sinha U; Pandey A; Eble JA; O'Callaghan CA; Watson SP
J Biol Chem; 2013 Feb; 288(7):5127-35. PubMed ID: 23264619
[TBL] [Abstract][Full Text] [Related]
18. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
[TBL] [Abstract][Full Text] [Related]
19. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.
Gardiner EE; Karunakaran D; Arthur JF; Mu FT; Powell MS; Baker RI; Hogarth PM; Kahn ML; Andrews RK; Berndt MC
Blood; 2008 Jan; 111(1):165-74. PubMed ID: 17848620
[TBL] [Abstract][Full Text] [Related]
20. SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice.
Cherpokova D; Bender M; Morowski M; Kraft P; Schuhmann MK; Akbar SM; Sultan CS; Hughes CE; Kleinschnitz C; Stoll G; Dragone LL; Watson SP; Tomlinson MG; Nieswandt B
Blood; 2015 Jan; 125(1):185-94. PubMed ID: 25301707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
